Kumar S, Suresh Kumar, S Kumar, Kumar Suresh

About

Dr. Suresh Kumar is serving as Scientist Grade-II at the National Institute of Biologicals, Ministry of Health & Family Welfare, Government of India, with over two decades of experience in biomedical research and regulatory science. He has developed specialized expertise in the quality control and evaluation of biologicals, particularly vaccines and therapeutic products, with a strong focus on in vivo experimental models and regulatory compliance.
He has extensive experience in laboratory animal science, including ethical handling, facility management, and implementation of national and international guidelines. His domain expertise further includes biosafety practices and biomedical waste management in high-containment laboratory environments.
Dr. Kumar’s research interests encompass epidemiology, neurobehavioral science, and the role of gut microbiota in metabolic and cardiovascular disorders. His work integrates experimental biology with applied and translational research approaches aimed at improving public health outcomes and advancing biological standardization.

Employment

• National Institute of Biologicals, Ministry of Health and Family Welfare, Goverment of India Scientist
  2015 - Present
• University of Delhi
  2011 - 2015
• National Brain Research Centre
  2006 - 2011

Education

Education history is unavailable.

Projects & Funding

Projects & funding information is unavailable.

Publications (27)

• Microbiota Transplantation as a Future Novel Therapeutic Strategy Approach
  Diseases 2026 DOI: 10.3390/diseases14020042
  +Save
• Unveiling roles of beneficial gut bacteria and optimal diets for health
  Frontiers in Microbiology 2025 DOI: 10.3389/fmicb.2025.1527755
  +Save
• Analysis of historical data to accelerate deletion of Abnormal Toxicity Test requirement for biologicals and vaccines
  Toxicology Reports 2024 DOI: 10.1016/j.toxrep.2024.101815
  +Save
• Animal Models for Gut Microbiome Research
  Animal Models in Research 2024 DOI: 10.1007/978-981-97-0048-6_10
  +Save
• Amoxicillin impact on pathophysiology induced by short term high salt diet in mice
  Scientific Reports 2022 DOI: 10.1038/s41598-022-21270-9
  +Save
• Amoxicillin modulates gut microbiota to improve short-term high-fat diet induced pathophysiology in mice
  Gut Pathogens 2022 DOI: 10.1186/s13099-022-00513-0
  +Save
• 3R initiatives for advanced biological safety tests BAOJ Microbiol Review Article Volume 6 Chung-Ming Chang
  BAOJ Microbiology 2022
  +Save
• Chitosan: Applications in Drug Delivery System
  Mini-Reviews in Medicinal Chemistry 2022 DOI: 10.2174/1389557522666220609102010
  +Save
• A COMPARATIVE EVALUATION OF THE IMPACT OF HIGH FAT AND HIGH SALT DIETARY COMPONENTS ON HUMAN AND MICE GUT MICROBIOTA
  International Journal of Biology, Pharmacy and Allied Sciences 2022 DOI: 10.31032/ijbpas/2022/11.5.6081
  +Save
• Basic Biostatistics for Laboratory Animal Science
  Essentials of Laboratory Animal Science: Principles and Practices 2021 DOI: 10.1007/978-981-16-0987-9_6
  +Save